Amgen CFO reports 16,860 RSUs, 17,201 options
Amgen’s EVP & CFO Thomas J.W. Dittrich reports initial RSU and stock option holdings granted under the company’s equity incentive plan.
Rhea-AI Filing Summary
AMGEN INC (AMGN) reported the initial equity holdings of executive vice president and chief financial officer Thomas J.W. Dittrich on a Form 3. He directly holds 16,860 Restricted Stock Units (RSUs) that will be settled in common stock and non-qualified stock options covering 17,201 shares of common stock at an exercise price of $410.95 per share.
The RSUs and the options were granted under Amgen’s Second Amended and Restated 2009 Equity Incentive Plan and each vest in four equal annual installments of 25% beginning on August 7, 2027. The options are exercisable on this schedule and expire on August 7, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Dittrich Thomas J.W.
Role
EVP & CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Nqso (Right to Buy) F2 | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Nqso (Right to Buy) — 17,201 contracts (Direct);
Common Stock — 16,860 shares (Direct)
Footnotes (2)
- F1. These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- F2. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027.
Key Figures
RSUs reported: 16,860 units
Underlying shares for options: 17,201 shares
Option exercise price: $410.95 per share
+2 more
5 metrics
RSUs reported
16,860 units
Restricted Stock Units that vest in four annual installments starting August 7, 2027
Underlying shares for options
17,201 shares
Common stock underlying non-qualified stock options held directly
Option exercise price
$410.95 per share
Exercise price for reported non-qualified stock options
Option expiration date
August 7, 2036
Expiration date of the non-qualified stock options
Vesting commencement date
August 7, 2027
Date when both RSUs and options begin vesting in four annual installments
Key Terms
Restricted Stock Units (RSUs), non-qualified stock options, Equity Incentive Plan
3 terms
Restricted Stock Units (RSUs) financial
"These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
FAQ
What equity holdings in AMGN did EVP & CFO Thomas J.W. Dittrich report on this Form 3?
He reported 16,860 Restricted Stock Units tied to Amgen common stock and non-qualified stock options over 17,201 underlying shares, all held directly, reflecting his initial reported ownership position.
What is the exercise price of Thomas Dittrich’s Amgen (AMGN) stock options?
The reported non-qualified stock options have an exercise price of $410.95 per share and relate to 17,201 underlying shares of Amgen common stock.
When do Thomas Dittrich’s Amgen (AMGN) RSUs and options begin vesting and how are they structured?
Both the RSUs and the non-qualified stock options vest in four equal annual installments of 25%, commencing on August 7, 2027, according to the filing’s footnotes.
When do Thomas Dittrich’s Amgen (AMGN) stock options expire?
The non-qualified stock options reported for Thomas Dittrich expire on August 7, 2036, after vesting in four equal annual installments starting August 7, 2027.
Under which plan were Thomas Dittrich’s Amgen (AMGN) RSUs and options granted?
Both the RSUs and the non-qualified stock options were granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, described in the filing as the Equity Incentive Plan.
How will Thomas Dittrich’s Amgen (AMGN) RSUs be settled once vested?
The filing states that vested RSUs will be paid in shares of Amgen common stock on a one-to-one basis, meaning each vested RSU converts into one share of common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
